Rituxan Articles
First Monoclonal Antibody OKed For Cancer In USA
31 July 1997
IDEC Shares Fall As Arthritis Drug Stalls
26 June 1997
IDEC Appointment
12 June 1997
1st-Qtr Revenues Down At IDEC
19 May 1997
Performance Still Sought From US Biotech Stocks
21 April 1997
IDEC 1996 Results
17 March 1997
IDEC's Rituximab Filed In USA & Europe
10 March 1997
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
